Crossmark

Design and Evaluation of Compritol®-Based Mesalazine Pellets and Tablets for Sustained Release Throughout the Gastrointestinal Tract

Published Online: 2025-09-05

Published Print: 2025-10

Authors

Lulu, Amirhossein

Akhgari, Abbas

Feizollahi, Sara

Abbaspour, Mohammadreza

Shahdadi Sardou, Hossein
License Information

Text and Data Mining valid from 2025-09-05

Version of Record valid from 2025-09-05
More Information

Article History

Received: 14 April 2025

Accepted: 15 August 2025

First Online: 5 September 2025

Declarations

:

: Not applicable.

: The authors declare no competing interests.

: The authors declare no conflict of interest.

Document is current